Oppenheimer & Close’s Taylor Devices TAYD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.67M Hold
113,594
4.21% 5
2026
Q1
$6.47M Sell
113,594
-12,000
-10% -$923K 4.08% 4
2025
Q4
$7.34M Hold
125,594
5% 3
2025
Q3
$6.16M Hold
125,594
4.16% 5
2025
Q2
$5.45M Hold
125,594
4.18% 7
2025
Q1
$4.05M Hold
125,594
3.34% 10
2024
Q4
$5.23M Hold
125,594
4.3% 5
2024
Q3
$6.27M Hold
125,594
5.03% 4
2024
Q2
$5.65M Hold
125,594
4.96% 5
2024
Q1
$6.25M Hold
125,594
5.42% 3
2023
Q4
$2.78M Hold
125,594
2.53% 16
2023
Q3
$2.68M Hold
125,594
2.67% 13
2023
Q2
$3.21M Hold
125,594
3.33% 11
2023
Q1
$2.52M Hold
125,594
2.49% 14
2022
Q4
$1.78M Hold
125,594
1.75% 19
2022
Q3
$1.28M Hold
125,594
1.38% 22
2022
Q2
$1.09M Buy
125,594
+23,662
+23% +$217K 1.25% 24
2022
Q1
$1.01M Buy
101,932
+1,338
+1% +$13.7K 0.87% 34
2021
Q4
$1.05M Buy
100,594
+36,844
+58% +$411K 0.98% 37
2021
Q3
$717K Buy
63,750
+37,855
+146% +$437K 0.69% 45
2021
Q2
$306K Buy
+25,895
New +$310K 0.28% 52

Other funds holding TAYD

Oppenheimer & Close's TAYD Position: Q2 2026 in Review

Oppenheimer & Close held its Taylor Devices (TAYD) position steady in Q2 2026 at 113,594 shares worth $6.67M. The position accounts for 4.21% of the portfolio, ranked #5.

Oppenheimer & Close first reported a position in TAYD in Q2 2021 and has held it in 21 quarters since. The position peaked at $7.34M in Q4 2025. 66 funds tracked by Wall St. Rank hold TAYD as of Q2 2026.

  • Oppenheimer & Close held 113,594 shares of Taylor Devices worth $6.67M as of Q2 2026.
  • Oppenheimer & Close left its Taylor Devices share count unchanged in Q2 2026.
  • Taylor Devices made up 4.21% of Oppenheimer & Close's portfolio in Q2 2026, its #5 holding.
  • Oppenheimer & Close first reported a position in Taylor Devices in Q2 2021 and has held it in 21 quarters since.
  • Oppenheimer & Close's Taylor Devices position peaked at $7.34M in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Taylor Devices as of Q2 2026.

Based on Oppenheimer & Close's 13F filing for Q2 2026, filed 12 Aug 2026.